[1]
Uzma Faridi, Fahad Al-Mutairi, Humaira Parveen, and Sahar Khateeb, “An in-vitro and in Silico Anticancer Study of FDA Approved Antidiabetic Drugs Glimepiride and Empagliflozin: Life Sciences-Biochemistry for better diagnosis and therapy”, Int J Life Sci Pharm Res, vol. 10, no. 2, pp. 52–57, Jun. 2022.